Puma Biotechnology Inc Share Price Nyse
Equities
US74587V1070
Biotechnology & Medical Research
Sales 2024 * | 22Cr 1.83TCr | Sales 2025 * | 23Cr 1.88TCr | Capitalization | 25Cr 2.07TCr |
---|---|---|---|---|---|
Net income 2024 * | 1Cr 83Cr | Net income 2025 * | 1.5Cr 125.25Cr | EV / Sales 2024 * | 1.13 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.1 x |
P/E ratio 2024 * |
21.2
x | P/E ratio 2025 * |
21.1
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.6% |
Latest transcript on Puma Biotechnology Inc
Managers | Title | Age | Since |
---|---|---|---|
Alan Auerbach
CEO | Chief Executive Officer | 54 | 15/10/15 |
Maximo Nougues
DFI | Director of Finance/CFO | 55 | 05/18/05 |
Alvin Wong
CTO | Chief Tech/Sci/R&D Officer | 71 | 01/13/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Miller
BRD | Director/Board Member | 67 | 23/18/23 |
Jay Moyes
BRD | Director/Board Member | 70 | 27/12/27 |
Alan Auerbach
CEO | Chief Executive Officer | 54 | 15/10/15 |
1st Jan change | Capi. | |
---|---|---|
+29.03% | 4.82TCr | |
-0.10% | 4.17TCr | |
+43.45% | 4.1TCr | |
-5.26% | 2.88TCr | |
+11.48% | 2.56TCr | |
-22.74% | 1.9TCr | |
+9.06% | 1.29TCr | |
+30.01% | 1.2TCr | |
-1.51% | 1.18TCr |